日本の細胞・遺伝子治療の市場規模、シェア、動向、予測治療タイプ、適応症、送達モード、エンドユーザー、地域別、2025-2033年

日本の細胞・遺伝子治療の市場規模、シェア、動向、予測治療タイプ、適応症、送達モード、エンドユーザー、地域別、2025-2033年

Report Format: PDF+Excel | Report ID: SR112025A27208

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Japan Cell and Gene Therapy Market - Introduction

    4.1    Overview
    4.2    Market Dynamics
    4.3    Industry Trends
    4.4    Competitive Intelligence
5   Japan Cell and Gene Therapy Market Landscape
    5.1    Historical and Current Market Trends (​2019-2024​)
    5.2    Market Forecast (​2025-2033​)
6   Japan Cell and Gene Therapy Market - Breakup by Therapy Type
    6.1    Cell Therapy
        6.1.1 Overview
        6.1.2 Historical and Current Market Trends (​2019-2024​)
        6.1.3 Market Segmentation
           6.1.3.1 Stem Cell
           6.1.3.2 Non-Stem Cell
        6.1.4 Market Forecast (​2025-2033​)
    6.2    Gene Therapy
        6.2.1 Overview
        6.2.2 Historical and Current Market Trends (​2019-2024​)
        6.2.3 Market Forecast (​2025-2033​)
7   Japan Cell and Gene Therapy Market - Breakup by Indication
    7.1    Cardiovascular Disease
        7.1.1 Overview
        7.1.2 Historical and Current Market Trends (​2019-2024​)
        7.1.3 Market Forecast (​2025-2033​)
    7.2    Oncology Disorder
        7.2.1 Overview
        7.2.2 Historical and Current Market Trends (​2019-2024​)
        7.2.3 Market Forecast (​2025-2033​)
    7.3    Genetic Disorder
        7.3.1 Overview
        7.3.2 Historical and Current Market Trends (​2019-2024​)
        7.3.3 Market Forecast (​2025-2033​)
    7.4    Infectious Disease
        7.4.1 Overview
        7.4.2 Historical and Current Market Trends (​2019-2024​)
        7.4.3 Market Forecast (​2025-2033​)
    7.5    Neurological Disorder
        7.5.1 Overview
        7.5.2 Historical and Current Market Trends (​2019-2024​)
        7.5.3 Market Forecast (​2025-2033​)
    7.6    Others
        7.6.1 Historical and Current Market Trends (​2019-2024​)
        7.6.2 Market Forecast (​2025-2033​)
8   Japan Cell and Gene Therapy Market - Breakup by Delivery Mode
    8.1    In-Vivo
        8.1.1 Overview
        8.1.2 Historical and Current Market Trends (​2019-2024​)
        8.1.3 Market Forecast (​2025-2033​)
    8.2    Ex-Vivo
        8.2.1 Overview
        8.2.2 Historical and Current Market Trends (​2019-2024​)
        8.2.3 Market Forecast (​2025-2033​)
9   Japan Cell and Gene Therapy Market - Breakup by End User
    9.1    Hospitals
        9.1.1 Overview
        9.1.2 Historical and Current Market Trends (​2019-2024​)
        9.1.3 Market Forecast (​2025-2033​)
    9.2    Cancer Care Centers
        9.2.1 Overview
        9.2.2 Historical and Current Market Trends (​2019-2024​)
        9.2.3 Market Forecast (​2025-2033​)
    9.3    Pharmaceutical and Biotechnology Companies
        9.3.1 Overview
        9.3.2 Historical and Current Market Trends (​2019-2024​)
        9.3.3 Market Forecast (​2025-2033​)
    9.4    Others
        9.4.1 Historical and Current Market Trends (​2019-2024​)
        9.4.2 Market Forecast (​2025-2033​)
10  Japan Cell and Gene Therapy Market – Breakup by Region 
    10.1    Kanto Region
        10.1.1 Overview
        10.1.2 Historical and Current Market Trends (​2019-2024​)
        10.1.3 Market Breakup by Therapy Type
        10.1.4 Market Breakup by Indication
        10.1.5 Market Breakup by Delivery Mode
        10.1.6 Market Breakup by End User
        10.1.7 Key Players
        10.1.8 Market Forecast (​2025-2033​)
    10.2    Kansai/Kinki Region
        10.2.1 Overview
        10.2.2 Historical and Current Market Trends (​2019-2024​)
        10.2.3 Market Breakup by Therapy Type
        10.2.4 Market Breakup by Indication
        10.2.5 Market Breakup by Delivery Mode
        10.2.6 Market Breakup by End User
        10.2.7 Key Players
        10.2.8 Market Forecast (​2025-2033​)
    10.3    Central/ Chubu Region
        10.3.1 Overview
        10.3.2 Historical and Current Market Trends (​2019-2024​)
        10.3.3 Market Breakup by Therapy Type
        10.3.4 Market Breakup by Indication
        10.3.5 Market Breakup by Delivery Mode
        10.3.6 Market Breakup by End User
        10.3.7 Key Players
        10.3.8 Market Forecast (​2025-2033​)
    10.4    Kyushu-Okinawa Region
        10.4.1 Overview
        10.4.2 Historical and Current Market Trends (​2019-2024​)
        10.4.3 Market Breakup by Therapy Type
        10.4.4 Market Breakup by Indication
        10.4.5 Market Breakup by Delivery Mode
        10.4.6 Market Breakup by End User
        10.4.7 Key Players
        10.4.8 Market Forecast (​2025-2033​)
    10.5    Tohoku Region
        10.5.1 Overview
        10.5.2 Historical and Current Market Trends (​2019-2024​)
        10.5.3 Market Breakup by Therapy Type
        10.5.4 Market Breakup by Indication
        10.5.5 Market Breakup by Delivery Mode
        10.5.6 Market Breakup by End User
        10.5.7 Key Players
        10.5.8 Market Forecast (​2025-2033​)
    10.6    Chugoku Region
        10.6.1 Overview
        10.6.2 Historical and Current Market Trends (​2019-2024​)
        10.6.3 Market Breakup by Therapy Type
        10.6.4 Market Breakup by Indication
        10.6.5 Market Breakup by Delivery Mode
        10.6.6 Market Breakup by End User
        10.6.7 Key Players
        10.6.8 Market Forecast (​2025-2033​)
    10.7    Hokkaido Region
        10.7.1 Overview
        10.7.2 Historical and Current Market Trends (​2019-2024​)
        10.7.3 Market Breakup by Therapy Type
        10.7.4 Market Breakup by Indication
        10.7.5 Market Breakup by Delivery Mode
        10.7.6 Market Breakup by End User
        10.7.7 Key Players
        10.7.8 Market Forecast (​2025-2033​)
    10.8    Shikoku Region
        10.8.1 Overview
        10.8.2 Historical and Current Market Trends (​2019-2024​)
        10.8.3 Market Breakup by Therapy Type
        10.8.4 Market Breakup by Indication
        10.8.5 Market Breakup by Delivery Mode
        10.8.6 Market Breakup by End User
        10.8.7 Key Players
        10.8.8 Market Forecast (​2025-2033​)
11  Japan Cell and Gene Therapy Market – Competitive Landscape
    11.1    Overview
    11.2    Market Structure
    11.3    Market Player Positioning
    11.4    Top Winning Strategies
    11.5    Competitive Dashboard
    11.6    Company Evaluation Quadrant
12  Profiles of Key Players
    12.1    Company A 
        12.1.1 Business Overview
        12.1.2 Services Offered
        12.1.3 Business Strategies
        12.1.4 SWOT Analysis
        12.1.5 Major News and Events
    12.2    Company B
        12.2.1 Business Overview
        12.2.2 Services Offered
        12.2.3 Business Strategies
        12.2.4 SWOT Analysis
        12.2.5 Major News and Events
    12.3    Company C
        12.3.1 Business Overview
        12.3.2 Services Offered
        12.3.3 Business Strategies
        12.3.4 SWOT Analysis
        12.3.5 Major News and Events
    12.4    Company D 
        12.4.1 Business Overview
        12.4.2 Services Offered
        12.4.3 Business Strategies
        12.4.4 SWOT Analysis
        12.4.5 Major News and Events
    12.5    Company E
        12.5.1 Business Overview
        12.5.2 Services Offered
        12.5.3 Business Strategies
        12.5.4 SWOT Analysis
        12.5.5 Major News and Events    
    
Company names have not been provided here as this is a sample TOC. Complete list to be provided in the final report. 

13  Japan Cell and Gene Therapy Market - Industry Analysis
    13.1    Drivers, Restraints, and Opportunities
        13.1.1 Overview
        13.1.2 Drivers
        13.1.3 Restraints
        13.1.4 Opportunities
    13.2   Porters Five Forces Analysis
        13.2.1 Overview
        13.2.2 Bargaining Power of Buyers
        13.2.3 Bargaining Power of Suppliers
        13.2.4 Degree of Competition
        13.2.5 Threat of New Entrants
        13.2.6 Threat of Substitutes
    13.3    Value Chain Analysis
14  Appendix

日本の細胞・遺伝子治療の市場規模、シェア、動向、予測治療タイプ、適応症、送達モード、エンドユーザー、地域別、2025-2033年
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials